BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 19189855)

  • 1. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
    Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
    Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
    Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the meq gene in the T cell subsets from chickens infected with Marek's disease virus serotype 1.
    Chang KS; Ohashi K; Lee SI; Takagi M; Onum M
    Jpn J Vet Res; 2005 Aug; 53(1-2):3-11. PubMed ID: 16190317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
    Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
    Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
    Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis.
    Renz KG; Cheetham BF; Walkden-Brown SW
    J Virol Methods; 2013 Jan; 187(1):144-52. PubMed ID: 23041147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Marek's disease virus can infect chicken brain microglia and promote the transcription of toll-like receptor 15 and 1LB genes].
    Yang QL; Chen H; Wei P
    Bing Du Xue Bao; 2011 Jan; 27(1):18-25. PubMed ID: 21462502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
    Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
    Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
    Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
    Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
    Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both homo and heterodimers of Marek's disease virus encoded Meq protein contribute to transformation of lymphocytes in chickens.
    Suchodolski PF; Izumiya Y; Lupiani B; Ajithdoss DK; Lee LF; Kung HJ; Reddy SM
    Virology; 2010 Apr; 399(2):312-21. PubMed ID: 20137800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative full-length sequence analysis of Marek's disease virus vaccine strain 814.
    Zhang F; Liu CJ; Zhang YP; Li ZJ; Liu AL; Yan FH; Cong F; Cheng Y
    Arch Virol; 2012 Jan; 157(1):177-83. PubMed ID: 21984218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
    Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
    Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of meq oncogene among Polish strains of Marek's disease.
    Woźniakowski G; Samorek-Salamonowicz E; Kozdruń W
    Pol J Vet Sci; 2010; 13(2):263-7. PubMed ID: 20731180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell culture attenuation eliminates rMd5ΔMeq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease.
    Lee LF; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Vaccine; 2012 Jul; 30(34):5151-8. PubMed ID: 22687760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
    Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine responses and inducible nitrous oxide synthase expression patterns in neonatal chicken brain microglia infected with very virulent Marek's disease virus strain YL040920.
    Yang Q; Wei P; Chen H
    Vet Immunol Immunopathol; 2011 Jul; 142(1-2):14-24. PubMed ID: 21501879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of recombinant Marek's disease virus (MDV) lacking the meq oncogene and co-expressing AIV-H9N2 HA and NA genes under control of exogenous promoters.
    Zhang Z; Chen W; Ma C; Zhao P; Duan L; Zhang F; Sun A; Li Y; Su H; Li S; Cui H; Cui Z
    J Biotechnol; 2014 Jul; 181():45-54. PubMed ID: 24709399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.